Form 4: Global Medical REIT Executive Receives Stock Grant
Insider Transaction (Form 4)
Matthew Fitzsimmons Whitlock, Chief Investment Officer of Global Medical REIT Inc., received 28,626 shares of common stock on August 27, 2026.
Summary
- Grant/award: acquired 28,626 Option (Right to buy) on August 27, 2026; holds 28,626 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Matthew Fitzsimmons Whitlock — Officer (Chief Investment Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-27 | Grant/award | Option (Right to buy) | 28,626 | — | — | 28,626 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-27 | Grant/award (28,626 shares) |
Keywords
insider transaction, Form 4, XRN, Chiron Real Estate Inc., neutral, Matthew Fitzsimmons Whitlock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.